Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis

Annals of Neurology

Volumn 81, Issue 2, 2017, Pages 227-239

  Güttsches, Anne Katrin ^a   Brady, Stefen ^b   Krause, Kathryn ^a,c   Maerkens, Alexandra ^a,c   Uszkoreit, Julian ^c   Eisenacher, Martin ^c   Schreiner, Anja ^a   Galozzi, Sara ^c   Mertens Rill, Janine ^a   Tegenthoff, Martin ^a   Holton, Janice L ^d   Harms, Matthew B ^e   Lloyd, Thomas E ^f   Vorgerd, Matthias ^a   Weihl, Conrad C ^g   Marcus, Katrin ^c   Kley, Rudolf A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN FYCO1; PROTEIN MAP1LC3; PROTEIN VARIANT; SEQUESTOSOME 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FYCO1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; AUTOPHAGY; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INCLUSION BODY MYOSITIS; MALE; MASS SPECTROMETRY; MYOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEOMICS; RIMMED VACUOLE; SPORADIC INCLUSION BODY MYOSITIS; VERY ELDERLY; WHOLE EXOME SEQUENCING; ALLELE; ANIMAL; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; PROCEDURES; RISK; SKELETAL MUSCLE;

AGED; AGED, 80 AND OVER; ALLELES; ANIMALS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; PROTEOMICS; RISK; TRANSCRIPTION FACTORS; VACUOLES;

EID: 85011342628     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24847     Document Type: Article

References (53)

1. Machado PM, Dimachkie MM, Barohn RJ. Sporadic inclusion body myositis: new insights and potential therapy. Curr Opin Neurol 2014;27:591–598.
2. Dimachkie MM. Idiopathic inflammatory myopathies. J Neuroimmunol 2011;231:32–42.
3. Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006;2:219–227.
4. Brady S, Squier W, Sewry C, et al. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 2014;4:e004552.
5. Rose MR. 188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, the Netherlands. Neuromuscul Disord 2013;23:1044–1055.
6. Güttsches A, Jacobsen F, Theiss C, et al. Human beta-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies. Innate Immun 2014;20:49–60.
7. Pinkus JL, Amato AA, Taylor JP, Greenberg SA. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis. Neuromuscul Disord 2014;24:611–616.
8. Weihl CC, Pestronk A. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers. Curr Opin Neurol 2010;23:482–488.
9. Askanas V, Engel WK. Molecular pathology and pathogenesis of inclusion-body myositis. Microsc Res Tech 2005;67:114–120.
10. Weihl CC, Iyadurai S, Baloh RH, et al. Autophagic vacuolar pathology in desminopathies. Neuromuscul Disord 2015;25:199–206.
11. Kley RA, Maerkens A, Leber Y, et al. A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients. Mol Cell Proteomics 2013;12:215–227.
12. Maerkens A, Kley RA, Olivé M, et al. Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. J Proteomics 2013;90:14–27.
13. Maerkens A, Olivé M, Schreiner A, et al. New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses. Acta Neuropathol Commun 2016;4:8.
14. Weihl CC, Baloh RH, Lee Y, et al. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord 2015;25:289–296.
15. Kley RA, van der Ven PF, Olivé M, et al. Impairment of protein degradation in myofibrillar myopathy caused by FLNC/filamin C mutations. Autophagy 2013;9:422–423.
16. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551–3567.
17. Uszkoreit J, Maerkens A, Perez-Riverol Y, et al. PIA: an intuitive protein inference engine with a Web-based user interface. J Proteome Res 2015;14:2988–2997.
18. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754–1760.
19. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078–2079.
20. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841–842.
21. Olsvik HL, Lamark T, Takagi K, et al. FYCO1 contains a C-terminally extended, LC3A/B-preferring LC3-interacting region (LIR) motif required for efficient maturation of autophagosomes during basal autophagy. J Biol Chem 2015;290:29361–29374.
22. Chen J, Ma Z, Jiao X, et al. Mutations in FYCO1 cause autosomal-recessive congenital cataracts. Am J Hum Genet 2011;88:827–838.
23. Olivé M, Goldfarb L, Dagvadorj A, et al. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases. Acta Neuropathol 2003;106:1–7.
24. Parker KC, Kong SW, Walsh RJ, et al. Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve 2009;39:739–753.
25. Wanschitz JV, Dubourg O, Lacene E, et al. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis. Neuromuscul Disord 2013;23:75–83.
26. Güttsches A, Balakrishnan-Renuka A, Kley RA, et al. ATOH8: a novel marker in human muscle fiber regeneration. Histochem Cell Biol 2015;143:443–452.
27. Pérez-Sala D, Oeste CL, Martinez AE, et al. Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding. Nat Commun 2015;6:7287.
28. Watabe M, Nakaki T. Protein kinase CK2 regulates the formation and clearance of aggresomes in response to stress. J Cell Sci 2011;124:1519–1532.
29. Wong ESP, Tan JMM, Soong W, et al. Autophagy-mediated clearance of aggresomes is not a universal phenomenon. Hum Mol Genet 2008;17:2570–2582.
30. Ahmed M, Machado PM, Miller A, et al. Targeting protein homeostasis in sporadic inclusion body myositis. Sci Transl Med 2016;8:331ra41.
31. Nogalska A, Engel WK, McFerrin J, et al. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem 2006;96:1491–1499.
32. Vattemi G, Engel WK, McFerrin J, Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 2004;164:1–7.
33. Li K, Pu C, Huang X, et al. Proteomic study of sporadic inclusion body myositis. Proteome Sci 2014;12:45.
34. Muth IE, Barthel K, Bahr M, et al. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid. J Neurol Neurosurg Psychiatry 2009;80:1344–1349.
35. Yam AY, Xia Y, Lin HJ, et al. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat Struct Mol Biol 2008;15:1255–1262.
36. Kitamura A, Kubota H, Pack C, et al. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nature Cell Biol 2006;8:1163–1170.
37. Tam S, Geller R, Spiess C, Frydman J. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 2006;8:1155–1162.
38. Neef DW, Jaeger AM, Gomez-Pastor R, et al. A direct regulatory interaction between chaperonin TRiC and stress-responsive transcription factor HSF1. Cell Rep 2014;9:955–966.
39. Guisbert E, Czyz DM, Richter K, et al. Identification of a tissue-selective heat shock response regulatory network. PLoS Genet 2013;9:e1003466.
40. Greenberg SA, Salajegheh M, Judge DP, et al. Etiology of limb girdle muscular dystrophy 1D/1E determined by laser capture microdissection proteomics. Ann Neurol 2012;71:141–145.
41. Schessl J, Zou Y, McGrath MJ, et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 2008;118:904–912.
42. Mastaglia FL, Needham M, Scott A, et al. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscul Disord 2009;19:763–765.
43. Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 2015;347:1436–1441.
44. Cady J, Koval ED, Benitez BA, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 2014;71:449–453.
45. Wild P, McEwan DG, Dikic I. The LC3 interactome at a glance. J Cell Sci 2014;127:3–9.
46. Pankiv S, Alemu EA, Brech A, et al. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport. J Cell Biol 2010;188:253–269.
47. Pankiv S, Johansen T. FYCO1: linking autophagosomes to microtubule plus end-directing molecular motors. Autophagy 2010;6:550–552.
48. Ching JK, Ju JS, Pittman SK, et al. Increased autophagy accelerates colchicine-induced muscle toxicity. Autophagy 2013;9:2115–2125.
49. Ju JS, Fuentealba RA, Miller SE, et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 2009;187:875–888.
50. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377–381.
51. Bucelli RC, Arhzaouy K, Pestronk A, et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 2015;85:665–674.
52. Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282:24131–24145.
53. Gang Q, Bettencourt C, Machado PM, et al. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol Aging 2016;47:218.e1–218.e9.